Litigation Against Acerus Pharmaceuticals Continues

Defendants include Chairman Ian Ihnatowycz and President Tom Rossi

TORONTO, April 5, 2016 /CNW/ - Eugene Melnyk, a significant shareholder in Acerus Pharmaceuticals Corporation (TSX:ASP), today announced the filing of a Statement of Claim in the Ontario Superior Court of Justice with respect to his litigation against Acerus Pharmaceuticals Corporation, company Chairman Ihor (aka Ian) Ihnatowycz and President Tom Rossi are named defendants and six other current or former directors and officers of the company are also referenced in the legal proceeding.  The claim is seeking, amongst other relief, the removal from the Board of Directors Ihor (aka Ian) Ihnatowycz and Tom Rossi, and the removal of Tom Rossi as CEO in addition to $145 million in damages, punitive and exemplary damages.

This filing is subsequent to the Notice of Action filed on March 4, 2016, which was also filed in the Ontario Superior Court of Justice.

SOURCE Eugene Melnyk

For further information: Ken Villazor,; Lorne Silver,

Organization Profile

Eugene Melnyk

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890